Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 251(2023) vom: 15. Juni, Seite 109628
Auteur principal: Koh, June-Young (Auteur)
Autres auteurs: Ko, Jae-Hoon, Lim, So Yun, Bae, Seongman, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Chung, Doo Ryeon, Chung, Chi Ryang, Kim, Sung-Han, Peck, Kyong Ran, Lee, Jeong Seok
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Baricitinib COVID-19 Glucocorticoid Severe Tocilizumab